Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Douglas Eastham

Physician Assistant, Surgical Franklin, TN Physician Assistant

NPI 1760796395 CMS profile 10554300

3000 Edward Curd Ln, Franklin, TN 37067

Open in the dashboard

General payments

$1,789

33 records reported · program years 2021–2025

Research payments

$3,000

Paid to them · 10 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Eastham of Franklin, TN is reported in the CMS Open Payments database as having received $1,789 across 33 general payments and $3,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $392 14
2024 General $1,196 15
2024 Research $3,000 10
2023 General $21 1
2021 General $181 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Eastham
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Douglas Eastham were reported at $392. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Douglas Eastham Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $181 $111 $36–$285 $132
2022 $0 $126 $44–$350 $149
2023 $21 $137 $47–$355 $160
2024 $1,196 $146 $49–$384 $164
2025 $392 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Intrinsic Therapeutics $1,565 28 payments
  2. Bioventus LLC $155 1 payment
  3. Radius Health, Inc. $26 2 payments
  4. Vertex Pharmaceuticals Incorporated $22 1 payment
  5. Cerapedics, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,362 32 payments
  2. Travel and Lodging $427 1 payment
Products named General payments · program years 2021–2025
  1. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $1,565 28 payments
  2. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $1,565 28 payments
  3. Durolane $155 1 payment
  4. Tymlos $26 2 payments
  5. JOURNAVX $22 1 payment
  6. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $21 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. Intrinsic Therapeutics $3,000 10 payments

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

890

Median for Physician Assistant: 241

Drug cost

$5,850

Median for Physician Assistant: $4,110

Branded share of claims

25.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 181 $1,198
Tizanidine Hcl Generic 151 $1,029
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 127 $932
Diclofenac Sodium Generic 69 $738
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 96 $564
Cyclobenzaprine Hcl Generic 73 $409
Pregabalin Generic 33 $387
Gabapentin Generic 33 $306
Tramadol Hcl Generic 68 $122
Meloxicam Generic 15 $72

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$36,973

Of which drugs: $99

Medicare patients

295

Average age 75

Services billed

1,421

173 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 31%
Chronic kidney disease 23%
Depression 23%
Diabetes 22%
Osteoporosis 21%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, ketorolac tromethamine, per 15 mg J1885 Office 46 101 $47
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 47 485 $39

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

43 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record